| Title | Author(s) | Year | View Count |
 | Lamivudine in hepatitis B-associated membranous nephropathy | Tang, S; Lai, FMM; Yun, HL; Tang, CSO; Kung, NNS; Yiu, WH; Kwok, WC; Leung, JCK; Kar, NL | 2005 | 112 |
| Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding | Chan, FKL; Ching, JYL; Hung, LCT; Wong, VWS; Leung, VKS; Kung, NNS; Hui, AJ; Wu, JCY; Leung, WK; Lee, VWY; Lee, KKC; Lee, YT; Lau, JYW; To, KF; Chan, HLY; Chung, SCS; Sung, JJY | 2005 | 115 |
 | Lamivudine in hepatitis B-associated membranous nephropathy | Tang, S; Lai, FM; Lui, RYH; Tang, CSO; Kung, NNS; Ho, YW; Chan, KW; Leung, JCK; Lai, KN | 2005 | 90 |
| Screening for colorectal cancer in Chinese: Comparison of fecal occult blood test, flexible sigmoidoscopy, and colonoscopy | Sung, JJY; Chan, FKL; Leung, WK; Wu, JCY; Lau, JYW; Ching, J; To, KF; Lee, YT; Luk, YW; Kung, NNS; Kwok, SPY; Li, MKW; Chung, SCS | 2003 | 68 |
 | Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized contolled study | Wong, BCY; Wang, WH; Lau, GKK; Wong, WM; Fung, FMY; Kung, NNS; Chu, KM; Lai, KC; Hu, HC; Hu, FL; Liu, XG; Chan, CK; Yuen, MF; Hui, WM; Lam, SK | 2001 | 241 |
| Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized controlled study | Wong, WM; Lam, SK; Wang, WH; Lau, GKK; Kung, NNS; Chu, KM; Lai, KC; Hu, W; Hu, FL; Liu, XG; Yuen, MF; Wong, BCY | 2001 | 89 |
| Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized controlled study | Wong, BCY; Wang, WH; Lau, GKK; Wong, WM; Fung, FMY; Kung, NNS; Chu, KM; Lai, KC; Hu, WHC; Hu, FL; Liu, XG; Chan, CK; Yuen, MF; Hui, WM; Lam, SK | 2001 | 67 |
| Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: A randomized controlled study | Wong, BCY; Wang, WH; Wong, WM; Lau, GKK; Fung, FMY; Kung, NNS; Chu, KM; Lai, KC; Hu, WHC; Hu, FL; Liu, XG; Chan, CK; Yuen, MF; Hui, WM; Lam, SK | 2001 | 95 |
| Incidence of gastroesophageal malignancy in patients with dyspepsia in Hong Kong: Implications for screening strategies | Sung, JJY; Lao, WC; Lai, MS; Li, TH; Chan, FKL; Wu, JCY; Leung, VKS; Luk, YW; Kung, NNS; Ching, JYL; Leung, WK; Lau, J; Chung, SJY | 2001 | 53 |
| β-Thalassemia intermedia caused by compound heterozygosity for Hb Malay (β codon 19 AAC→AGC; Asn→Ser) and codons 41/42 (-CTTT) β0-thalassemia mutation | Ma, SK; Chow, EYD; Chan, AYY; Kung, NNS; Waye, JS; Chan, LC; Chui, DHK | 2000 | 114 |
|
